Chunghwa Chemical Synthesis & Biotech Co., Ltd.
Research Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762.TW) on Bullrun: market cap TWD 2.67B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker1762.TW
- ExchangeTW
- CountryTaiwan
- SectorHealthcare
- IndustryBiotechnology
- CurrencyTWD
- Market capTWD 2.67B
- Financial periodQ2 2026
- RevenueTWD 305.18M
- Net incomeTWD 41.53M
- Free cash flowTWD 93.75M
- Gross margin37.9%
Valuation Snapshot
latest market cap is TWD 2.67B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | TWD 2.67B | n/a | n/a | 0.19 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.19 TWD.
About Chunghwa Chemical Synthesis & Biotech Co., Ltd.
Chunghwa Chemical Synthesis & Biotech Co., Ltd. engages in the manufacturing, sale, and wholesale of western medicine in Taiwan and internationally.
Related stock research
Other Healthcare stocks
Synbio Tech Inc. (1295.TWO)
Sinphar Pharmaceutical Co.,Ltd. (1734.TW)
SYN-TECH Chem. & Pharm. Co., Ltd. (1777.TWO)
Level Biotechnology Inc. (3118.TWO)
GenMont Biotech Incorporation (3164.TW)
Medigen Biotechnology Corp. (3176.TWO)
Sagittarius Life Science Corp (3205.TWO)
NeoCore Technology Co., Ltd. (4131.TWO)
Abnova (Taiwan) Corporation (4133.TW)
Adimmune Corporation (4142.TW)
TaiMed Biologics Inc. (4147.TWO)
TaiGen Biopharmaceuticals Holdings Limited (4157.TWO)
Frequently asked questions
What is Chunghwa Chemical Synthesis & Biotech Co., Ltd.'s market cap?
Chunghwa Chemical Synthesis & Biotech Co., Ltd.'s market capitalization is TWD 2.67B.
What does Chunghwa Chemical Synthesis & Biotech Co., Ltd. do?
Chunghwa Chemical Synthesis & Biotech Co., Ltd. engages in the manufacturing, sale, and wholesale of western medicine in Taiwan and internationally.